Further, some studies showed that molecular subtypes had no predictive value for ALN status [41], while others showed that the triple-negative breast cancer patients had the lowest incidence of ALN metastasis and the HER-2 subtype had the highest incidence of ALN metastasis [42, 43]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.